Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1

BACKGROUND: Anti-GAD65 autoantibodies (GAD65-Abs) may occur in patients with epilepsy and other neurological disorders, but the clinical significance is not clear-cut. Whereas high levels of GAD65-Abs are considered pathogenic in neuropsychiatric disorders, low or moderate levels are only considered...

Descripción completa

Detalles Bibliográficos
Autores principales: Zong, Shenghua, Vinke, Anita M., Du, Peng, Hoffmann, Carolin, Mané-Damas, Marina, Molenaar, Peter C., Damoiseaux, Jan G. M. C., Losen, Mario, Rouhl, Rob P. W., Martinez-Martinez, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248002/
https://www.ncbi.nlm.nih.gov/pubmed/37305746
http://dx.doi.org/10.3389/fneur.2023.1111063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248002/
https://www.ncbi.nlm.nih.gov/pubmed/37305746
http://dx.doi.org/10.3389/fneur.2023.1111063

Ejemplares similares